PRCT vs. IRTC, AXNX, TNDM, NARI, ICUI, IART, ATEC, MMSI, LMAT, and NVCR
Should you be buying PROCEPT BioRobotics stock or one of its competitors? The main competitors of PROCEPT BioRobotics include iRhythm Technologies (IRTC), Axonics (AXNX), Tandem Diabetes Care (TNDM), Inari Medical (NARI), ICU Medical (ICUI), Integra LifeSciences (IART), Alphatec (ATEC), Merit Medical Systems (MMSI), LeMaitre Vascular (LMAT), and NovoCure (NVCR). These companies are all part of the "surgical & medical instruments" industry.
iRhythm Technologies (NASDAQ:IRTC) and PROCEPT BioRobotics (NASDAQ:PRCT) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, community ranking, media sentiment, analyst recommendations, risk, dividends and valuation.
iRhythm Technologies received 361 more outperform votes than PROCEPT BioRobotics when rated by MarketBeat users. Likewise, 66.04% of users gave iRhythm Technologies an outperform vote while only 62.22% of users gave PROCEPT BioRobotics an outperform vote.
iRhythm Technologies presently has a consensus target price of $134.00, suggesting a potential upside of 35.76%. PROCEPT BioRobotics has a consensus target price of $61.20, suggesting a potential downside of 10.18%. Given PROCEPT BioRobotics' higher probable upside, equities analysts clearly believe iRhythm Technologies is more favorable than PROCEPT BioRobotics.
89.5% of PROCEPT BioRobotics shares are owned by institutional investors. 0.7% of iRhythm Technologies shares are owned by insiders. Comparatively, 17.4% of PROCEPT BioRobotics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
iRhythm Technologies has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500. Comparatively, PROCEPT BioRobotics has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500.
iRhythm Technologies has a net margin of -25.33% compared to iRhythm Technologies' net margin of -66.12%. iRhythm Technologies' return on equity of -41.35% beat PROCEPT BioRobotics' return on equity.
PROCEPT BioRobotics has lower revenue, but higher earnings than iRhythm Technologies. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than iRhythm Technologies, indicating that it is currently the more affordable of the two stocks.
In the previous week, PROCEPT BioRobotics had 3 more articles in the media than iRhythm Technologies. MarketBeat recorded 5 mentions for PROCEPT BioRobotics and 2 mentions for iRhythm Technologies. PROCEPT BioRobotics' average media sentiment score of 0.94 beat iRhythm Technologies' score of 0.69 indicating that iRhythm Technologies is being referred to more favorably in the media.
Summary
iRhythm Technologies beats PROCEPT BioRobotics on 9 of the 16 factors compared between the two stocks.
Get PROCEPT BioRobotics News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PRCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
PROCEPT BioRobotics Competitors List
Related Companies and Tools
